Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
34.19
+1.92 (5.95%)
At close: Mar 6, 2026
SHA:688062 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 1,193 | 1,651 | 2,491 | 96.54 |
Short-Term Investments | - | 35.87 | 35.26 | - | - |
Trading Asset Securities | - | 3.77 | 14.88 | 60.12 | - |
Cash & Short-Term Investments | 1,482 | 1,232 | 1,701 | 2,551 | 96.54 |
Cash Growth | 20.26% | -27.56% | -33.32% | 2542.47% | -82.38% |
Accounts Receivable | - | 38.34 | 17.51 | 0.07 | 0.14 |
Other Receivables | - | 100.05 | 112.27 | 82.65 | 33.01 |
Receivables | - | 138.39 | 129.78 | 82.73 | 33.15 |
Inventory | - | 211.68 | 159.3 | 79.05 | 40.11 |
Other Current Assets | - | 122.84 | 57.48 | 65.12 | 74.93 |
Total Current Assets | - | 1,705 | 2,048 | 2,778 | 244.74 |
Property, Plant & Equipment | - | 2,053 | 1,935 | 1,263 | 811.64 |
Long-Term Investments | - | 46.66 | 41.95 | 20.2 | 18.95 |
Goodwill | - | 118.77 | 118.77 | 118.77 | 118.77 |
Other Intangible Assets | - | 152.81 | 139.72 | 161.31 | 179.4 |
Long-Term Deferred Charges | - | 6.39 | 0.98 | 6.13 | 12.71 |
Other Long-Term Assets | - | 192.76 | 170.98 | 271.93 | 209.07 |
Total Assets | - | 4,276 | 4,455 | 4,619 | 1,595 |
Accounts Payable | - | 100.23 | 62.32 | 45.21 | 39.69 |
Accrued Expenses | - | 153.03 | 138.12 | 82.25 | 57.53 |
Short-Term Debt | - | 921.6 | 209.27 | 100.14 | 10.82 |
Current Portion of Long-Term Debt | - | 113.65 | 1.59 | 0.6 | 0.15 |
Current Portion of Leases | - | 31.52 | 26.96 | 21.02 | 18.83 |
Current Income Taxes Payable | - | - | 3.34 | - | - |
Current Unearned Revenue | - | 36.01 | 13.52 | 36.65 | 63.53 |
Other Current Liabilities | - | 185.67 | 361.26 | 159.27 | 79.85 |
Total Current Liabilities | - | 1,542 | 816.39 | 445.14 | 270.41 |
Long-Term Debt | - | 1,006 | 887.72 | 492.12 | 132.05 |
Long-Term Leases | - | 142.97 | 167.11 | 160.57 | 172.72 |
Long-Term Unearned Revenue | - | 27.07 | 10.59 | 11.03 | 11.47 |
Other Long-Term Liabilities | - | 1.53 | - | - | - |
Total Liabilities | - | 2,720 | 1,882 | 1,109 | 586.65 |
Common Stock | - | 399.6 | 399.6 | 399.6 | 299.7 |
Additional Paid-In Capital | - | 5,959 | 5,931 | 5,812 | 2,456 |
Retained Earnings | - | -4,795 | -3,751 | -2,698 | -1,743 |
Comprehensive Income & Other | - | 5.08 | 4.8 | 1.56 | -2.6 |
Total Common Equity | 761.1 | 1,569 | 2,584 | 3,516 | 1,011 |
Minority Interest | - | -13.1 | -10.45 | -5.08 | -2.18 |
Shareholders' Equity | 945.58 | 1,556 | 2,573 | 3,511 | 1,009 |
Total Liabilities & Equity | - | 4,276 | 4,455 | 4,619 | 1,595 |
Total Debt | 2,549 | 2,216 | 1,293 | 774.45 | 334.58 |
Net Cash (Debt) | -1,067 | -983.91 | 408.4 | 1,777 | -238.03 |
Net Cash Growth | - | - | -77.01% | - | - |
Net Cash Per Share | -2.67 | -2.46 | 1.02 | 4.54 | -0.79 |
Filing Date Shares Outstanding | 401.68 | 399.6 | 399.6 | 399.6 | 299.7 |
Total Common Shares Outstanding | 399.4 | 399.6 | 399.6 | 399.6 | 299.7 |
Working Capital | - | 163.47 | 1,231 | 2,333 | -25.68 |
Book Value Per Share | 1.91 | 3.93 | 6.47 | 8.80 | 3.37 |
Tangible Book Value | 494.14 | 1,297 | 2,325 | 3,236 | 712.64 |
Tangible Book Value Per Share | 1.24 | 3.25 | 5.82 | 8.10 | 2.38 |
Buildings | - | 753.02 | 181.83 | 3.06 | 3.06 |
Machinery | - | 1,206 | 653.69 | 440.39 | 420.08 |
Construction In Progress | - | 240.87 | 1,131 | 804.49 | 313.24 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.